Liabilities / Assets
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
990 • Fiscal year 2017 • EIN 43-1972800
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
51st percentile
Higher net margin than 51% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
17th percentile
Faster asset growth than 17% of similar nonprofits.
Revenue Growth
13th percentile
Faster revenue growth than 13% of similar nonprofits.
Assets
Down$168,366
Down $61,982 (-27%) from 2016
Net Assets
Down$168,366
Down $61,510 (-27%) from 2016
Liabilities
Down$0
Down $472 (-100%) from 2016
Revenue
Down$108,872
Down $63,850 (-37%) from 2016
Expenses
Down$104,673
Down $64,748 (-38%) from 2016
Net Income
Up$4,199
Up $898 (+27%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Formed to improve the level of care for asthma, allergy, and inmmunology patients in israel. It provides educational preceptorhsips in the usa for isaraeli allegry physician trainees. Afi also provides medical education lectures and conferences given in isarael by visiting expert allergy/immunoligy specialists. Afi will provide financial support for clinical research in allergy/immunology by israeli allergy/immunology trainees. Afi will help to establish collage relations between america and israel. Alergists to advance meedical research can care for asthma and allergy patiens israel.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.